Sleep Medicine Reviews最新文献

英文中文

Editorial: Building on excellence: Advancing sleep medicine together

IF 11.2 1区医学 Q1 CLINICAL NEUROLOGY

Sleep Medicine Reviews

Pub Date : 2025-03-12 DOI: 10.1016/j.smrv.2025.102079

Monica L. Andersen (Editor-in-Chief of Sleep Medicine Reviews)

引用次数: 0

Mixed or misaligned? Effects of cognitive behavioral therapy for insomnia across the spectrum of alcohol use disorder

IF 11.2 1区医学 Q1 CLINICAL NEUROLOGY

Sleep Medicine Reviews

Pub Date : 2025-03-10 DOI: 10.1016/j.smrv.2025.102078

Wilfred R. Pigeon (PhD) , Todd M. Bishop , J. Todd Arnedt

引用次数: 0

Reply to commentary: Time to target perioperative sleep disturbances to enhance postoperative outcomes

IF 11.2 1区医学 Q1 CLINICAL NEUROLOGY

Sleep Medicine Reviews

Pub Date : 2025-03-05 DOI: 10.1016/j.smrv.2025.102075

Martin F. Bjurström , Andrea Niklasson , Patrick H. Finan , Eva Kosek

引用次数: 0

A bench-to-bedside narrative review of the sleep-social-oxytocin nexus

IF 11.2 1区医学 Q1 CLINICAL NEUROLOGY

Sleep Medicine Reviews

Pub Date : 2025-02-27 DOI: 10.1016/j.smrv.2025.102077

Joel S. Raymond , Wendy M. Troxel , Michael T. Bowen

Although recognition of the significant reciprocal interplay between sleep and social processes has grown over the past two decades, theoretical frameworks conceptualising this interplay have predominantly focused on psychosocial factors. The current lack of attention to putative neurobiological substrates and physiological mechanisms that may facilitate the dynamics of sleep-social relationships limits interdisciplinary research into sleep and clinical treatment of sleep problems and disorders. Thus, this narrative review hypothesises that the neuropeptide oxytocin represents a promising candidate physiological substrate underpinning sleep-social interplay, and integrates the endogenous oxytocin system into a novel tripartite biopsychosocial framework—the sleep-social-oxytocin nexus.

The current narrative review outlines the theoretical rationale for the existence of reciprocal sleep-social-oxytocin interactions, and examines the clinical and preclinical evidence for interactions between sleep processes, social processes, and the oxytocin system, highlighting the paucity of experimental research that addresses all three nexus factors. Subsequently, we explore important clinical implications of the sleep-social-oxytocin nexus: comorbidities between sleep, social, and oxytocinergic dysfunction in sleep and other psychiatric disorders, the emerging therapeutic potential of oxytocin-based therapeutics, and potential adjunctive interventions to achieve optimal treatment outcomes. We conclude by proposing future avenues for research and clinical implementation warranted within this space.

{"title":"A bench-to-bedside narrative review of the sleep-social-oxytocin nexus","authors":"Joel S. Raymond , Wendy M. Troxel , Michael T. Bowen","doi":"10.1016/j.smrv.2025.102077","DOIUrl":"10.1016/j.smrv.2025.102077","url":null,"abstract":"<div><div>Although recognition of the significant reciprocal interplay between sleep and social processes has grown over the past two decades, theoretical frameworks conceptualising this interplay have predominantly focused on psychosocial factors. The current lack of attention to putative neurobiological substrates and physiological mechanisms that may facilitate the dynamics of sleep-social relationships limits interdisciplinary research into sleep and clinical treatment of sleep problems and disorders. Thus, this narrative review hypothesises that the neuropeptide oxytocin represents a promising candidate physiological substrate underpinning sleep-social interplay, and integrates the endogenous oxytocin system into a novel tripartite biopsychosocial framework—the sleep-social-oxytocin nexus.</div><div>The current narrative review outlines the theoretical rationale for the existence of reciprocal sleep-social-oxytocin interactions, and examines the clinical and preclinical evidence for interactions between sleep processes, social processes, and the oxytocin system, highlighting the paucity of experimental research that addresses all three nexus factors. Subsequently, we explore important clinical implications of the sleep-social-oxytocin nexus: comorbidities between sleep, social, and oxytocinergic dysfunction in sleep and other psychiatric disorders, the emerging therapeutic potential of oxytocin-based therapeutics, and potential adjunctive interventions to achieve optimal treatment outcomes. We conclude by proposing future avenues for research and clinical implementation warranted within this space.</div></div>","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"81 ","pages":"Article 102077"},"PeriodicalIF":11.2,"publicationDate":"2025-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143578330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The effects of L-theanine consumption on sleep outcomes: A systematic review and meta-analysis 食用左旋茶氨酸对睡眠结果的影响：系统回顾与荟萃分析

IF 11.2 1区医学 Q1 CLINICAL NEUROLOGY

Sleep Medicine Reviews

Pub Date : 2025-02-25 DOI: 10.1016/j.smrv.2025.102076

Amanda Bulman , Nathan M. D’Cunha , Wolfgang Marx , Murray Turner , Andrew McKune , Nenad Naumovski

This systematic review ansd meta-analysis aimed to evaluate the effects of L-theanine, a non-proteinogenic amino acid found in tea, on sleep outcomes. Literature searches were conducted in five electronic databases (APA PsycINFO, CINAHL, Medline, Scopus, Web of Science), and one register (Cochrane Central Register of Controlled Trials) from inception until September 2024. Randomised controlled trials investigating the effects of L-theanine supplementation on sleep quality in humans of all ages and health status were included. Nineteen articles (N = 897 participants) were selected and 18 included in the meta-analysis. L-theanine was shown to significantly improve subjective sleep onset latency (SMD = 0.15, 95 % CI [0.01, 0.29], p = 0.04; n = 10 studies), subjective daytime dysfunction (SMD = 0.33, 95 % CI [0.16, 0.49], p < 0.001; n = 9 studies), and overall subjective sleep quality score (SMD = 0.43, 95 % CI [0.04, 0.83], p = 0.03; n = 12 studies). The findings indicate the potential use of L-theanine in the management of sleep disturbances; however, the lack of studies on “pure” L-theanine warrants further investigation. Future studies are needed to determine the adequate dose and duration of L-theanine supplementation for improving and maintaining sleep quality in healthy and clinical populations.

{"title":"The effects of L-theanine consumption on sleep outcomes: A systematic review and meta-analysis","authors":"Amanda Bulman , Nathan M. D’Cunha , Wolfgang Marx , Murray Turner , Andrew McKune , Nenad Naumovski","doi":"10.1016/j.smrv.2025.102076","DOIUrl":"10.1016/j.smrv.2025.102076","url":null,"abstract":"<div><div>This systematic review ansd meta-analysis aimed to evaluate the effects of L-theanine, a non-proteinogenic amino acid found in tea, on sleep outcomes. Literature searches were conducted in five electronic databases <strong>(</strong>APA PsycINFO, CINAHL, Medline, Scopus, Web of Science), and one register (Cochrane Central Register of Controlled Trials) from inception until September 2024. Randomised controlled trials investigating the effects of L-theanine supplementation on sleep quality in humans of all ages and health status were included. Nineteen articles (N = 897 participants) were selected and 18 included in the meta-analysis. L-theanine was shown to significantly improve subjective sleep onset latency (SMD = 0.15, 95 % CI [0.01, 0.29], <em>p</em> = 0.04; n = 10 studies), subjective daytime dysfunction (SMD = 0.33, 95 % CI [0.16, 0.49], <em>p</em> < 0.001; n = 9 studies), and overall subjective sleep quality score (SMD = 0.43, 95 % CI [0.04, 0.83], <em>p</em> = 0.03; n = 12 studies<em>)</em>. The findings indicate the potential use of L-theanine in the management of sleep disturbances; however, the lack of studies on “pure” L-theanine warrants further investigation. Future studies are needed to determine the adequate dose and duration of L-theanine supplementation for improving and maintaining sleep quality in healthy and clinical populations.</div></div>","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"81 ","pages":"Article 102076"},"PeriodicalIF":11.2,"publicationDate":"2025-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143578329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Time to treat pre-surgical symptoms of insomnia?

IF 11.2 1区医学 Q1 CLINICAL NEUROLOGY

Sleep Medicine Reviews

Pub Date : 2025-02-21 DOI: 10.1016/j.smrv.2025.102068

Janet M. Mullington

引用次数: 0

Comment on Niklasson et al. The relationship between preoperative sleep disturbance and acute postoperative pain control: A systematic review and meta-analysis

IF 11.2 1区医学 Q1 CLINICAL NEUROLOGY

Sleep Medicine Reviews

Pub Date : 2025-02-21 DOI: 10.1016/j.smrv.2025.102074

Qiang Zong , Xiao Li , Hanrong Cheng

引用次数: 0

The association between sleep quality and telomere attrition: A systematic review and meta-analysis comprising 400,212 participants

IF 11.2 1区医学 Q1 CLINICAL NEUROLOGY

Sleep Medicine Reviews

Pub Date : 2025-02-20 DOI: 10.1016/j.smrv.2025.102073

Arina Jocelyn Fostitsch , Guido Schwarzer , Maria Buchgeister , Werner Surbeck , Claas Lahmann , Kai Spiegelhalder , Lukas Frase , Derek Spieler

Psychosocial stressors accelerate telomere attrition, a biomarker of cell aging, whereas good sleep is hypothesized to be a mitigating factor. However, methodological aspects - particularly underpowered studies, inconsistent findings, and multiple approaches to assessing sleep – demonstrate the need for a meta-analysis. After PROSPERO registration, we conducted a systematical search of the following databases until June 2024 to identify studies examining the relationship between sleep quality and telomere length in adult humans: CINAHL, Cochrane Library, MEDLINE, PsychINFO, PubMed, Web of Science, and Google Scholar. In total, 29 studies met inclusion criteria for the systematic review according to the preferred reporting items for systematic reviews and meta-analysis guidelines (PRISMA), 19 of which provided data that was appropriate for meta-analytic calculations. We identified the Pittsburgh sleep quality index (PSQI) global score (odds ratio (OR) 1.24, CI 95 % [1.03; 1.50], p = 0.02), sleep-related daytime impairments (OR 1.01 [1.00; 1.02], p = 0.04), and wake after sleep onset (WASO) time (OR 1.28 [1.12; 1.47], p < 0.01) as to be significantly associated with telomere attrition. Thus, the subtle telomere attrition-mitigating role of sleep has been demonstrated based on a sufficiently large body of data and defined aspects of sleep quality.

{"title":"The association between sleep quality and telomere attrition: A systematic review and meta-analysis comprising 400,212 participants","authors":"Arina Jocelyn Fostitsch , Guido Schwarzer , Maria Buchgeister , Werner Surbeck , Claas Lahmann , Kai Spiegelhalder , Lukas Frase , Derek Spieler","doi":"10.1016/j.smrv.2025.102073","DOIUrl":"10.1016/j.smrv.2025.102073","url":null,"abstract":"<div><div>Psychosocial stressors accelerate telomere attrition, a biomarker of cell aging, whereas good sleep is hypothesized to be a mitigating factor. However, methodological aspects - particularly underpowered studies, inconsistent findings, and multiple approaches to assessing sleep – demonstrate the need for a meta-analysis. After PROSPERO registration, we conducted a systematical search of the following databases until June 2024 to identify studies examining the relationship between sleep quality and telomere length in adult humans: CINAHL, Cochrane Library, MEDLINE, PsychINFO, PubMed, Web of Science, and Google Scholar. In total, 29 studies met inclusion criteria for the systematic review according to the preferred reporting items for systematic reviews and meta-analysis guidelines (PRISMA), 19 of which provided data that was appropriate for meta-analytic calculations. We identified the Pittsburgh sleep quality index (PSQI) global score (odds ratio (OR) 1.24, CI 95 % [1.03; 1.50], p = 0.02), sleep-related daytime impairments (OR 1.01 [1.00; 1.02], p = 0.04), and wake after sleep onset (WASO) time (OR 1.28 [1.12; 1.47], p < 0.01) as to be significantly associated with telomere attrition. Thus, the subtle telomere attrition-mitigating role of sleep has been demonstrated based on a sufficiently large body of data and defined aspects of sleep quality.</div></div>","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"80 ","pages":"Article 102073"},"PeriodicalIF":11.2,"publicationDate":"2025-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143641784","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Prevalence of poor sleep quality among stroke survivors: A meta-analysis and systematic review

IF 11.2 1区医学 Q1 CLINICAL NEUROLOGY

Sleep Medicine Reviews

Pub Date : 2025-02-07 DOI: 10.1016/j.smrv.2025.102070

Yue-Ying Wang , Jia-Xin Li , Yu-Fei Liu , Wei Bai , He-Li Sun , Tong Leong Si , Zhaohui Su , Teris Cheung , Gabor S. Ungvari , Chee H. Ng , Qinge Zhang , Yu-Tao Xiang

Background

Poor sleep quality is common among stroke survivors, but the prevalence rates vary between studies. This meta-analysis examined the global prevalence of poor sleep quality and its moderating factors among stroke survivors.

Method

Relevant publications were systematically searched in PubMed, Web of Science, Embase, PsycINFO, CNKI and WanFang. The pooled prevalence of poor sleep quality and the sleep quality component scores with 95 % confidence intervals (CIs) were calculated using a random-effects model.

Result

Totally, 68 studies comprising 14,845 participants who fulfilled study entry criteria were included for analyses. All included studies used the Pittsburgh sleep quality index (PSQI) to assess sleep quality. The global prevalence of poor sleep quality in stroke survivors was 50.26 % (95%CI: 46.69%–53.82 %). Stroke location in left hemisphere was associated with a lower risk of poor sleep quality, while stroke type (i.e., cerebral infarction) and lower-middle-income countries were associated with higher risk of poor sleep quality in stroke survivors.

Conclusion

In this meta-analysis, poor sleep quality was common among stroke survivors and was moderated by stroke location, type, and countries income. To address the adverse impacts of poor sleep quality in stroke survivors, regular screening and appropriate intervention should be provided in a timely fashion.

{"title":"Prevalence of poor sleep quality among stroke survivors: A meta-analysis and systematic review","authors":"Yue-Ying Wang , Jia-Xin Li , Yu-Fei Liu , Wei Bai , He-Li Sun , Tong Leong Si , Zhaohui Su , Teris Cheung , Gabor S. Ungvari , Chee H. Ng , Qinge Zhang , Yu-Tao Xiang","doi":"10.1016/j.smrv.2025.102070","DOIUrl":"10.1016/j.smrv.2025.102070","url":null,"abstract":"<div><h3>Background</h3><div>Poor sleep quality is common among stroke survivors, but the prevalence rates vary between studies. This meta-analysis examined the global prevalence of poor sleep quality and its moderating factors among stroke survivors.</div></div><div><h3>Method</h3><div>Relevant publications were systematically searched in PubMed, Web of Science, Embase, PsycINFO, CNKI and WanFang. The pooled prevalence of poor sleep quality and the sleep quality component scores with 95 % confidence intervals (CIs) were calculated using a random-effects model.</div></div><div><h3>Result</h3><div>Totally, 68 studies comprising 14,845 participants who fulfilled study entry criteria were included for analyses. All included studies used the Pittsburgh sleep quality index (PSQI) to assess sleep quality. The global prevalence of poor sleep quality in stroke survivors was 50.26 % (95%CI: 46.69%–53.82 %). Stroke location in left hemisphere was associated with a lower risk of poor sleep quality, while stroke type (i.e., cerebral infarction) and lower-middle-income countries were associated with higher risk of poor sleep quality in stroke survivors.</div></div><div><h3>Conclusion</h3><div>In this meta-analysis, poor sleep quality was common among stroke survivors and was moderated by stroke location, type, and countries income. To address the adverse impacts of poor sleep quality in stroke survivors, regular screening and appropriate intervention should be provided in a timely fashion.</div></div>","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"80 ","pages":"Article 102070"},"PeriodicalIF":11.2,"publicationDate":"2025-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143445480","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The impact of pharmacotherapy for premenstrual dysphoric disorder on sleep

IF 11.2 1区医学 Q1 CLINICAL NEUROLOGY

Sleep Medicine Reviews

Pub Date : 2025-02-07 DOI: 10.1016/j.smrv.2025.102069

Elisa M.S. Meth , Diana A. Nôga , Manon Dubol , Pei Xue , Inger Sundström-Poromaa , Christian Benedict

Premenstrual dysphoric disorder (PMDD) affects a subset of women of reproductive age, characterized by severe mood disturbances and physical symptoms during the luteal phase of the menstrual cycle. Symptoms include mood swings, irritability, anxiety, fatigue, physical discomfort, and disruptions to sleep and circadian rhythms, such as altered melatonin secretion. Despite the prevalence of these symptoms, the impact of PMDD treatments on sleep and circadian markers, like melatonin, remains insufficiently understood. This review examines how dysregulated serotonin signaling, disrupted allopregnanolone activity (a neurosteroid derived from progesterone), and aberrant circadian rhythms contribute to PMDD. It also explores the effects of pharmacological treatments, including selective serotonin reuptake inhibitors, on sleep and melatonin regulation, and how these factors influence treatment outcomes. Additionally, the use of hypnotics and sedatives to manage sleep disturbances in PMDD is considered, weighing their potential benefits and risks. A deeper understanding of the interaction between PMDD symptoms, sleep, and circadian rhythms is crucial for developing more effective treatments. Further research is needed to explore the relationship between symptom management, sleep patterns, and circadian function in PMDD, and to determine how these factors can be optimized to improve clinical outcomes and quality of life for women affected by the disorder.

{"title":"The impact of pharmacotherapy for premenstrual dysphoric disorder on sleep","authors":"Elisa M.S. Meth , Diana A. Nôga , Manon Dubol , Pei Xue , Inger Sundström-Poromaa , Christian Benedict","doi":"10.1016/j.smrv.2025.102069","DOIUrl":"10.1016/j.smrv.2025.102069","url":null,"abstract":"<div><div>Premenstrual dysphoric disorder (PMDD) affects a subset of women of reproductive age, characterized by severe mood disturbances and physical symptoms during the luteal phase of the menstrual cycle. Symptoms include mood swings, irritability, anxiety, fatigue, physical discomfort, and disruptions to sleep and circadian rhythms, such as altered melatonin secretion. Despite the prevalence of these symptoms, the impact of PMDD treatments on sleep and circadian markers, like melatonin, remains insufficiently understood. This review examines how dysregulated serotonin signaling, disrupted allopregnanolone activity (a neurosteroid derived from progesterone), and aberrant circadian rhythms contribute to PMDD. It also explores the effects of pharmacological treatments, including selective serotonin reuptake inhibitors, on sleep and melatonin regulation, and how these factors influence treatment outcomes. Additionally, the use of hypnotics and sedatives to manage sleep disturbances in PMDD is considered, weighing their potential benefits and risks. A deeper understanding of the interaction between PMDD symptoms, sleep, and circadian rhythms is crucial for developing more effective treatments. Further research is needed to explore the relationship between symptom management, sleep patterns, and circadian function in PMDD, and to determine how these factors can be optimized to improve clinical outcomes and quality of life for women affected by the disorder.</div></div>","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"80 ","pages":"Article 102069"},"PeriodicalIF":11.2,"publicationDate":"2025-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143396227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

下一页尾页

类型

全部化学•材料生命科学医学物理工程技术环境•农林材料科学地球科学法学管理学化学环境科学与生态学计算机科学教育学经济学农林科学人文科学生物学数学物理与天体物理心理学综合性期刊其他工业工程理学历史学农学文学信息工程

数据库

全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley

期刊

Sleep Medicine Reviews

全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.

﹀